I'll spell it out: B L M H I S U N D E R V A L U E D Shares of Bloom Health Partners (CSE: BLMH) saw a big sell off this week, causing SP to fall from $.19 to $.11. Price action has slowed to a halt today after SP fell nearly 30% yesterday, showing signs it may have hit a bottom.
This is potentially good news, as BLMH is expected to release its fiscal yearly results in the next few weeks. The company has outperformed its yearly guidance, and is on track to beat it by over 10%. Right now, BLMH is valued at less than a quarter of its revenues to date. Based on its YTD EBITDA, the company should theoretically be valued at nearly 14x its current valuation.
Hopefully share price begins to consolidate at these lows, and pressure builds towards catalyst potential for BLMH’s yearly earnings.
BLMH.c is currently trading at $.11 million, valued at $5.24 million.
https://ceo.ca/@newsfile/bloom-health-partners-reports-profitable-fiscal-q3